Laura And Isaac Perlmutter Cancer Center
New York, New York, United States
Medical center in New York City, New York
240 E 38th St 19th Floor, New York, NY 10016
About Laura And Isaac Perlmutter Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
NYU Langone Health
3
Regeneron Pharmaceuticals
3
Eli Lilly and Company
2
Pfizer
2
Celldex Therapeutics
1
Nektar Therapeutics
1
NextCure, Inc.
1
Sumitomo Pharma Oncology, Inc.
1
Taiho Oncology, Inc.
1
Takeda
1
Clinical Trials at Laura And Isaac Perlmutter Cancer Center
During the past decade, Laura And Isaac Perlmutter Cancer Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
2015-03-01
2019-06-24
Completed
34
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
2015-01-01
2018-12-12
Completed
175
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
2015-02-02
2019-11-18
Completed
398
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
2016-02-24
2019-12-19
Completed
507
Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study
2015-08-01
2023-11-01
Withdrawn
0
Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
2016-09-01
2020-03-12
Completed
7
Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
2016-11-29
2022-05-02
Completed
19
Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
2016-10-01
2021-01-01
Completed
12
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Laura And Isaac Perlmutter Cancer Center" #1 sponsor was "NYU Langone Health" with 3 trials, followed by "Regeneron Pharmaceuticals" with 3 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Celldex Therapeutics"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Laura And Isaac Perlmutter Cancer Center"
#1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Laura And Isaac Perlmutter Cancer Center
According to Clinical.Site data, the most researched conditions in "Laura And Isaac Perlmutter Cancer Center" are
"Melanoma" (3 trials), "Advanced Malignancies" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Neoplasm Metastasis" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Laura And Isaac Perlmutter Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Laura And Isaac Perlmutter Cancer Center
Most popular intervention types in "Laura And Isaac Perlmutter Cancer Center" are "Drug" (13 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (3 trials), "AZD1775" (1 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Laura And Isaac Perlmutter Cancer Center
The vast majority of trials in "Laura And Isaac Perlmutter Cancer Center" are
15 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Laura And Isaac Perlmutter Cancer Center
Currently, there are NaN active trials in "Laura And Isaac Perlmutter Cancer Center".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Laura And Isaac Perlmutter Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Laura And Isaac Perlmutter Cancer Center, 10 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".